0000950142-15-000742.txt : 20150414
0000950142-15-000742.hdr.sgml : 20150414
20150414201439
ACCESSION NUMBER: 0000950142-15-000742
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150414
FILED AS OF DATE: 20150414
DATE AS OF CHANGE: 20150414
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cidara Therapeutics, Inc.
CENTRAL INDEX KEY: 0001610618
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 461537286
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6310 NANCY RIDGE DRIVE
STREET 2: SUITE 101
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-752-6170
MAIL ADDRESS:
STREET 1: 6310 NANCY RIDGE DRIVE
STREET 2: SUITE 101
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: K2 THERAPEUTICS, INC.
DATE OF NAME CHANGE: 20140611
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Seachaid Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001639140
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36912
FILM NUMBER: 15770344
BUSINESS ADDRESS:
STREET 1: 801 CAPITOLA DRIVE, SUITE 5
CITY: DURHAM
STATE: NC
ZIP: 27713
BUSINESS PHONE: 919-354-1800
MAIL ADDRESS:
STREET 1: 801 CAPITOLA DRIVE, SUITE 5
CITY: DURHAM
STATE: NC
ZIP: 27713
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Purcell Dennis J
CENTRAL INDEX KEY: 0001297291
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36912
FILM NUMBER: 15770345
MAIL ADDRESS:
STREET 1: AUXILIUM PHARMACEUTICALS, INC.
STREET 2: 160 WEST GERMANTOWN PIKE
CITY: NORRISTOWN
STATE: PA
ZIP: 19401
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SCHIFF ANDREW N
CENTRAL INDEX KEY: 0001172252
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36912
FILM NUMBER: 15770346
MAIL ADDRESS:
STREET 1: PLANET ZANETT INC
STREET 2: 135 E 57TH ST
CITY: NEW YORK
STATE: NY
ZIP: 10022
FORMER NAME:
FORMER CONFORMED NAME: SCHIFF DR DREW
DATE OF NAME CHANGE: 20020426
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: AISLING CAPITAL PARTNERS LLC
CENTRAL INDEX KEY: 0001376171
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36912
FILM NUMBER: 15770347
BUSINESS ADDRESS:
STREET 1: 888 SEVENTH AVENUE
STREET 2: 30TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10106
BUSINESS PHONE: (212) 651-6380
MAIL ADDRESS:
STREET 1: 888 SEVENTH AVENUE
STREET 2: 30TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10106
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: AISLING CAPITAL PARTNERS, LP
CENTRAL INDEX KEY: 0001376172
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36912
FILM NUMBER: 15770348
BUSINESS ADDRESS:
STREET 1: 888 SEVENTH AVENUE
STREET 2: 30TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10106
BUSINESS PHONE: (212) 651-6380
MAIL ADDRESS:
STREET 1: 888 SEVENTH AVENUE
STREET 2: 30TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10106
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Aisling Capital II LP
CENTRAL INDEX KEY: 0001350778
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36912
FILM NUMBER: 15770349
BUSINESS ADDRESS:
STREET 1: 88 SEVENTH AVE 30TH FL
CITY: NEW YORK
STATE: NY
ZIP: 10106
MAIL ADDRESS:
STREET 1: 88 SEVENTH AVE 30TH FL
CITY: NEW YORK
STATE: NY
ZIP: 10106
3
1
es1500485_3-cidara.xml
OWNERSHIP DOCUMENT
X0206
3
2015-04-14
0
0001610618
Cidara Therapeutics, Inc.
CDTX
0001350778
Aisling Capital II LP
888 7TH AVENUE
30TH FLOOR
NEW YORK
NY
10106
0
0
1
0
0001376172
AISLING CAPITAL PARTNERS, LP
888 7TH AVENUE,
30TH FLOOR
NEW YORK
NY
10106
0
0
1
0
0001376171
AISLING CAPITAL PARTNERS LLC
888 7TH AVENUE,
30TH FLOOR
NEW YORK
NY
10106
0
0
1
0
0001172252
SCHIFF ANDREW N
888 7TH AVENUE
30TH FLOOR
NEW YORK
NY
10106
0
0
1
0
0001297291
Purcell Dennis J
888 7TH AVENUE,
30TH FLOOR
NEW YORK
NY
10106
0
0
1
0
0001639140
Seachaid Pharmaceuticals, Inc.
C/O AISLING CAPITAL LLC
888 7TH AVENUE, 30TH FL
NEW YORK
NY
10106
0
0
1
0
Common Stock
703092
I
By Seachaid Pharmaceuticals, LLC.
Convertible Preferred Stock
0
Common Stock
351518
I
By Aisling Capital II, L.P.
Shares of common stock, par value $0.0001 per share (the "Common Shares") of Cidara Therapeutics, Inc. (the "Issuer") are held directly by Seachaid Pharmaceuticals, LLC. ("Seachaid").
Shares of preferred stock, par value $0.0001 per share (the "Preferred Shares") are convertible at any time, at the holder's election, and have no expiration date. Upon the consummation of the Issuer's initial public offering, the Preferred Shares will automatically convert into Common Shares on a 25.4-to-1 basis.
The Preferred Shares are directly held by Aisling Capital II, LP ("Aisling").
The investment committee of Aisling holds sole voting and dispositive power over the Common Shares held by Seachaid and the Preferred Shares held by Aisling. Aisling is a majority-owner of Seachaid. Aisling Capital Partners LP ("Aisling GP") is the general partner of Aisling and Aisling Capital Partners LLC ("Aisling Partners") is the general partner of Aisling GP. The individual managing members (collectively, the "Managers") of Aisling Partners are Dennis Purcell, Dr. Andrew Schiff and Steve Elms. Aisling GP, Aisling Partners, and the Managers share voting and dispositive power over the shares directly held by Aisling and Seachaid. (Cont'd in FN5)
(Cont'd from FN4) Each of the Reporting Persons disclaims beneficial ownership of the Common Shares and Preferred Shares, except to the extent of such person's pecuniary interest. Mr. Elms has filed a separate Form 3 with respect to his beneficial ownership of the Common Shares and Preferred Shares. Following the closing of the Issuer's initial public offering, the Reporting Persons will no longer own more than 10% of the Issuer's Common Shares.
/s/ Aisling Capital II, LP, by /s/ Lloyd Appel
2015-04-14
/s/ Aisling Capital Partners, LLC, by /s/ Lloyd Appel
2015-04-14
/s/ Aisling Capital Partners, LP, by /s/ Lloyd Appel
2015-04-14
/s/ Andrew N. Schiff
2015-04-14
/s/ Dennis J. Purcell
2015-04-14
Seachaid Pharmaceuticals, LLC, by /s/ Lloyd Appel
2015-04-14